Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian M Thompson

Showing results (301-310 of 484) with videos related to

Pageof 49
Sort By:
Cancer Causes & Control : CCC|November 1, 2014
Prospective study of human herpesvirus type 8 serostatus and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention TrialSiobhan Sutcliffe, Cathee Till, Frank J Jenkins, et al.
Journal of the National Cancer Institute|February 26, 2014
Serum biomarkers of bone metabolism in castration-resistant prostate cancer patients with skeletal metastases: results from SWOG 0421Primo N Lara, Benjamin Ely, David I Quinn, et al.
The Journal of Urology|January 25, 2017
Racial Variation in the Utility of Urinary Biomarkers PCA3 and T2ERG in a Large Multicenter StudyPadraic G O'Malley, Daniel P Nguyen, Bashir Al Hussein Al Awamlh, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 13, 2006
Obesity, adipokines, and prostate cancer in a prospective population-based studyJacques Baillargeon, Elizabeth A Platz, David P Rose, et al.
CA: a Cancer Journal for Clinicians|March 5, 2010
American Cancer Society guideline for the early detection of prostate cancer: update 2010Andrew M D Wolf, Richard C Wender, Ruth B Etzioni, et al.
The Lancet. Oncology|May 9, 2014
Addressing overdiagnosis and overtreatment in cancer: a prescription for changeLaura J Esserman, Ian M Thompson, Brian Reid, et al.
The Prostate|April 21, 2015
Prostate stromal cell telomere shortening is associated with risk of prostate cancer in the placebo arm of the Prostate Cancer Prevention TrialChristopher M Heaphy, Gaurav Gaonkar, Sarah B Peskoe, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 31, 2016
Metformin for Reducing Racial/Ethnic Difference in Prostate Cancer Incidence for Men with Type II DiabetesChen-Pin Wang, Donna M Lehman, Yui-Wing F Lam, et al.
Psychopharmacology|May 30, 2019
Vortioxetine reverses medial prefrontal cortex-mediated cognitive deficits in male rats induced by castration as a model of androgen deprivation therapy for prostate cancerAlexandra M Sharp, Suphada Lertphinyowong, Samantha S Yee, et al.
BJU International|January 20, 2011
Provider and partner interactions in the treatment decision-making process for newly diagnosed localized prostate cancerSteven B Zeliadt, David F Penson, Carol M Moinpour, et al.
Pageof 49

Showing results (301-310 of 484) with videos related to

Sort By:
Pageof 49
Cancer Causes & Control : CCC|November 1, 2014
Prospective study of human herpesvirus type 8 serostatus and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention TrialSiobhan Sutcliffe, Cathee Till, Frank J Jenkins, et al.
Journal of the National Cancer Institute|February 26, 2014
Serum biomarkers of bone metabolism in castration-resistant prostate cancer patients with skeletal metastases: results from SWOG 0421Primo N Lara, Benjamin Ely, David I Quinn, et al.
The Journal of Urology|January 25, 2017
Racial Variation in the Utility of Urinary Biomarkers PCA3 and T2ERG in a Large Multicenter StudyPadraic G O'Malley, Daniel P Nguyen, Bashir Al Hussein Al Awamlh, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 13, 2006
Obesity, adipokines, and prostate cancer in a prospective population-based studyJacques Baillargeon, Elizabeth A Platz, David P Rose, et al.
CA: a Cancer Journal for Clinicians|March 5, 2010
American Cancer Society guideline for the early detection of prostate cancer: update 2010Andrew M D Wolf, Richard C Wender, Ruth B Etzioni, et al.
The Lancet. Oncology|May 9, 2014
Addressing overdiagnosis and overtreatment in cancer: a prescription for changeLaura J Esserman, Ian M Thompson, Brian Reid, et al.
The Prostate|April 21, 2015
Prostate stromal cell telomere shortening is associated with risk of prostate cancer in the placebo arm of the Prostate Cancer Prevention TrialChristopher M Heaphy, Gaurav Gaonkar, Sarah B Peskoe, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 31, 2016
Metformin for Reducing Racial/Ethnic Difference in Prostate Cancer Incidence for Men with Type II DiabetesChen-Pin Wang, Donna M Lehman, Yui-Wing F Lam, et al.
Psychopharmacology|May 30, 2019
Vortioxetine reverses medial prefrontal cortex-mediated cognitive deficits in male rats induced by castration as a model of androgen deprivation therapy for prostate cancerAlexandra M Sharp, Suphada Lertphinyowong, Samantha S Yee, et al.
BJU International|January 20, 2011
Provider and partner interactions in the treatment decision-making process for newly diagnosed localized prostate cancerSteven B Zeliadt, David F Penson, Carol M Moinpour, et al.
Pageof 49